Abstract:The title compound, 6C5H9N2 (+)·3SiF6 (2-)·CH3OH, (I), was prepared by recrystallization of the crude salt from methanol along with solvent-free 2C5H9N2 (+)·SiF6 (2-) (II). Crystals of these solvatomorphs can be separated manually. The solvate (I) crystallizes in a rare hexa-gonal space group P6/mcc. Its asymmetric unit comprises one half of an imidazolium cation bis-ected by the crystallographic m-plane, one-sixth and one-twelfth of two crystallographically independent SiF6 (2-) dianions (Si atoms are located on the 3.2 and 6/m inversion centres), and one-twelfth of a methanol mol-ecule (C atoms are situated on the 622 inversion centres, other atoms are disordered between general positions). In (I), all F atoms of 3.2-located SiF6 (2-) dianions participate in the formation of symmetry-equivalent contacts to the H atoms of imidazolium fragments, thus forming rod-type ensembles positioned on the -6 axes. These 'pillar' rods are, in turn, F⋯H inter-linked through SiF6 (2-) dianions disordered around the 6/m centres. The twelvefold disordered methanol mol-ecules are appended to this array by O-H⋯F hydrogen bonds to the 6/m located SiF6 (2-) dianions. In terms of graph-set notation, the first and second level networks in (I) are N 1 = C 2 (2)(7)[3R 4 (4)(14)]D 2 (2)(4) and N 2 = D 2 (2)(5) (C-H⋯O hydrogen bonds are not considered). After locating all symmetrically independent atoms in the cation and anions, there remained a strong (> 3 e Å(-3)) residual electron density peak located at the 622 inversion centre. Treatment of this pre-refined model with the SQUEEZE procedure in PLATON [Spek (2009). Acta Cryst. D65, 148-155] revealed two voids per unit cell, indicative of the presence of the solvent methanol mol-ecule disordered about the 622 inversion centre.

1-Benzyl-3-[3-(naphthalen-2-yl-oxy)prop-yl]imidazolium Hexa-Fluoro-phosphate.

1-Methyl-3-(4-vinylbenzyl)imidazolium Hexafluorophosphate

3,3′-Dimethyl-1,1′-[(1,3-dihydroxypropane-2,2-diyl)dimethylidene]diimidazolium Bis(hexafluorophosphate)

1-Dehydroabietyl-4,5-diphenyl-1h-imidazole

3,3&#8242;-Dimethyl-1,1&#8242;-[(1,3-dihydroxypropane-2,2-diyl)dimethylidene]diimidazolium bis(hexafluorophosphate)

2-Amino-4-methylpyridinium 4-Aminobenzoate

2,2′-Diamino-4,4′-bi-1,3-thiazolium Fumarate

1-Oxo-3-phenyl-1,2-dihydro-pyrido[1,2-a]-pyrazin-5-ium Hexafluorophosphate

Bis(3-hydroxypyridinium) Fumarate

1,10-Phenanthrolinium 4-Chloro-2-hydroxybenzoate–1,10-phenanthroline–4-chloro-2-hydroxybenzoic Acid (1/1/1)

1,1'-[(1,3-Dihydroxypropane-2,2-diyl)dimethylene]dipyridinium bis-(hexa-fluoro-phosphate)

Synthesis and crystal structure of N , N ′-dicyclohexylimidazolium hexafluorophosphate

Crystal structure of 3-(2-ethoxy-2-oxoethyl)-1-isopropyl-1H-imidazol-3-ium hexafluoridophosphate(V), C 20 H 34 F 12 N 4 P 2

1-Ethyl-3-(2,4,6-trimethylphenyl)imidazolium Tetrafluoroborate

4-(3-Fluoro-4-meth-oxy-phen-yl)-1-(4-meth-oxy-phen-yl)-5-(3,4,5-trimeth-oxy-phen-yl)-1H-imidazole

1,1′-[(1,3-Dihydroxypropane-2,2-diyl)dimethylene] dipyridinium bis(hexafluorophosphate)

3,3′-Dimethyl-1,1′-(butane-1,4-diyl)diimidazolium Bis(tetrafluoroborate)

Tris{2-[2-(1-methyl)imidazolyl]methyliminoethyl}-aminezinc(II) dihexafluorophosphate

3,3&#8242;-Dimethyl-1,1&#8242;-(butane-1,4-diyl)diimidazolium bis(tetrafluoroborate)

Bis(1,3-dimethyl-1H-imidazolium) hexa-fluoro-silicate methanol 0.33-solvate

1-(4-Fluorophenyl)-5-(4-methoxyphenyl)pyrazolidin-3-one